数字农科院2.0

Human 8-cell embryos enable efficient induction of disease-preventive mutations without off-target effect by cytosine base editor

文献类型： 外文期刊

作者： Wei, Yinghui;Zhang, Meiling;Hu, Jing;Zhou, Yingsi;Xue, Mingxing;Yin, Jianhang;Liu, Yuanhua;Feng, Hu;Zhou, Ling;Li, Zhifang;Wang, Dongshuang;Zhang, Zhiguo;Zhou, Yin;Liu, Hongbin;Yao, Ning;Zuo, Erwei;Hu, Jiazhi;Du, Yanzhi;Li, Wen;Xu, Chunlong;Yang, Hui

作者机构：

关键词： human embryo;APOE4;disease-preventive mutations;base editor

期刊名称： PROTEIN & CELL

ISSN： 1674-800X

年卷期： 2023 年

页码：

收录情况： SCIE（2023版） ; ; CSCD（2023-2024年度） ; ; 科技核心（2023版）

摘要： Approximately 140 million people worldwide are homozygous carriers of APOE4 (epsilon 4), a strong genetic risk factor for late onset familial and sporadic Alzheimer's disease (AD), 91% of whom will develop AD at earlier age than heterozygous carriers and noncarriers. Susceptibility to AD could be reduced by targeted editing of APOE4, but a technical basis for controlling the off-target effects of base editors is necessary to develop low-risk personalized gene therapies. Here, we first screened eight cytosine base editor variants at four injection stages (from 1- to 8-cell stage), and found that FNLS-YE1 variant in 8-cell embryos achieved the comparable base conversion rate (up to 100%) with the lowest bystander effects. In particular, 80% of AD-susceptible epsilon 4 allele copies were converted to the AD-neutral epsilon 3 allele in human epsilon 4-carrying embryos. Stringent control measures combined with targeted deep sequencing, whole genome sequencing, and RNA sequencing showed no DNA or RNA off-target events in FNLS-YE1-treated human embryos or their derived stem cells. Furthermore, base editing with FNLS-YE1 showed no effects on embryo development to the blastocyst stage. Finally, we also demonstrated FNLS-YE1 could introduce known protective variants in human embryos to potentially reduce human susceptivity to systemic lupus erythematosus and familial hypercholesterolemia. Our study therefore suggests that base editing with FNLS-YE1 can efficiently and safely introduce known preventive variants in 8-cell human embryos, a potential approach for reducing human susceptibility to AD or other genetic diseases.

分类号：

  • 相关文献

[1]Genome Editing Strategies Towards Enhancement of Rice Disease Resistance. Rukmini Mishra,Wei Zheng,Raj Kumar Joshi,Zhao Kaijun. 2021

[2]Targeted deaminase-free T-to-G and C-to-K base editing in rice by fused human uracil DNA glycosylase variants. Wu, Yinghuang,Wang, Xueying,Wang, Haoyu,Han, Ying,Wang, Yaxuan,Zou, Chunyu,Zhu, Jian-Kang,Li, Ming. 2025

作者其他论文 更多>>